REACT COVID-19: Anti-Cytokine Therapy in COVID-19+ Patients [COVID-19]

• Research type

  Research Study

• Full title

  REACT COVID-19: Real world Evidence for Anti-Cytokine Therapy in COVID-19, an international, multi-center, observational study

• IRAS ID

  282992

• Contact name

  Krish Patel

• Contact email

  krish.patel@swedish.org

• Sponsor organisation

  Swedish Medical Center

• Clinicaltrials.gov Identifier

  not applicable, not applicable

• Duration of Study in the UK

  1 years, 0 months, 2 days

• Research summary

  This is an international, multicenter, observational study to collect clinical data in patients with suspected or confirmed COVID-19 who have been or will be treated with anti-cytokine therapy. Data will be used to assess relationships between previously administered anti-cytokine therapies, clinical outcomes, resource utilization, and serial changes in cytokine profiles and other correlative biomarkers. This protocol will not specify any therapeutic\ninterventions and is an observational study to collect clinical and correlative data only.

• REC name

  N/A

• REC reference

  N/A